Trastuzumab - an overview

trastuzumab  On April 5, 2024, the Food and Drug Administration granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia

Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be In 2006, trastuzumab plus chemotherapy was approved to treat patients after their HER2-overexpressing breast tumors were surgically removed

Trastuzumab exposure for a relatively short period does not seem to substantially affect the pregnancy outcome In contrast, a more prolonged trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients